chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a registered nurse, referring to an unspecified number of patients of unknown genders and ages. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On an unknown date, the patients were vaccinated with improperly stored dose of M-M-R II which had Lot number M034856 with an expiration date of 27-JUL-2018, lot # reported as M002073 with an expiration date of 19-APR-2018 and lot # reported as M020073 with an expiration date of 19-APR-2018 (strength, dose and route were not reported) for prophylaxis. It was confirmed that all the vaccines were reconstituted with sterile diluent (lot # and expiration date were not reported) which was stored in correct temperature range. No adverse effects were reported. It was reported that the vaccines were exposed to temperature of >-15 centigrade degrees (°C) but <-10 °C range, for a time frame of 1 hour. The temperature excursion was not recorded by a data logger and no previous excursions were reported for the vaccines. There was no product quality complaint involved. This is one of the several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1705USA002377: US-009507513-1705USA002376:
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On 04-NOV-2016, the patient was vaccinated with an improperly stored dose of PROQUAD (lot # M014301, expiry date: 22-SEP-2017) (route: subcutaneous) (incorrect product storage). The vaccine was stored at a temperature of -0.13 degree C for 5.75 hours. The vaccine had a previous temperature excursion of -14.93 degree C for 15 minutes and -14.48 degree C for 15 minutes. Data logger was involved. No known adverse effects. The outcome of the events was unknown. Additional information has been requested.
Excessive redness at injection site, large lump at injection site size of Brussel sprout, hot to touch, threw up once, spitting up, stuffy nose, dry cough. Used detoxing mud mask on injection site for following week.
Event: Ringing in right ear Treatment: Prednisone (prescribed today 8/5/21) Outcome: Not known yet
Within 15 minutes of vax, inject site rxn characterized by a red, raised, circular rash measuring 2 to 3 inches in diameter.
Pfizer 4/8/21, 5/6/21. Positive on 10/4/22.
Fever  100.6 for 8 hours severe nausea  severe chills for 3 hours fatigue
NOTALGIA PARESTHETICA 3/31/2022 ARTHROPATHY OF CERVICAL FACET NOTALGIA PARESTHETICA 3/31/2022 CANCER METASTATIC TO BONE    GERD (GASTROESOPHAGEAL REFLUX DISEASE) NOTALGIA PARESTHETICA 3/31/2022 FEVER W CHILLS NOTALGIA PARESTHETICA 3/31/2022 CANCER METASTATIC TO BONE
Associate complained of headache and that she didnt feel well. Associate noted to have a swollen tongue and rapid response was called. Associate was taken to ED. HR 80. BP 100/70
After dose 3, I ended up having a frozen shoulder, possibly due to the administration of the vaccine.  I visited an orthopedic surgeon but no surgery.  I had a lot of pain, and my range of motion was inhibited.  I went to physical therapy for several months.   I had dose 4 in the left arm as well.  I had a burning sensation in my arm.  I don?t have a frozen shoulder yet, but I have a lot of pain into the shoulder.  I will have an MRI in February 2023.
Sudden onset of (L) sided supraclavicular LAD that was TTP - obvious from across the room.
Loss is hearing in both ears. Sensorineural loss bilaterally.  Prescribed hearing aids.
fever, chills, swollen arm 24 hours it lasted  took tylenol every 5-6 hours for fever
Redness, warm to the touch the size of tennis ball, then couple Days turning into light bruising .
Pt recv vax on 5/3/99; 3 hr post vax pt exp rt arm pain/ red/ swollen, feverish, headache, dizzy, chills, abdomen pain x 3 days; tx=Tylenol
Rash, dizziness, fever, muscle aches, joint pain, headache, injection site pain, fatigue, and sniffles. Dizziness gone on day 2. Rash gone after 10 days.  Fever gone after2 days.  Muscle aches, joint pain, headache, fatigue, and sniffles gone on day 3.  Injection site pain gone after10 days.
Pt developed a fever of 103 at about 24 hours after the shot. Labs and exams do not identify any other likely source.
Patient came to office this am with skin papules with erythematous basis, few vesicles.
This is a spontaneous report from a contactable consumer (Patient). A 50-years-old non pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration into left arm on 04Mar2021 17:00 (at the age of 50-years-old) as dose 1, single for covid-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing, drug hypersensitivity (Penicillin) from an unknown date and unknown if ongoing, covid-19 (Prior to the vaccination) from an unknown date and unknown if ongoing. It was reported that she was not a pregnant at the time of vaccination. No other vaccine received within four weeks. It was reported received other medications in two weeks. The patient reported all common side effects for 4 days then on 09Mar2021 17:00, developed productive seal cough, fever, swollen lymph nodes, unbearable body aches in all parts of body- eyes, bottom of feet, hands now going on 7 days after first dose with little improvement. Therapeutic measures were not taken. The patient underwent lab tests and procedures which included sars-cov-2 test (saliva test): negative on 08Mar2021. The outcome of productive seal cough, fever, swollen lymph nodes, unbearable body aches in all parts of body - eyes, bottom of feet, hands was not recovered.  No follow-up attempts are possible; information about batch/ lot number cannot be obtained.
Patient admitted fur to chest pain and dyspnea and found to have myopericarditis after 2nd dose of COVID-19 Pzifer vaccine. Vaccine was administered at pharmacy.  First dose received on 5/15/2021, second dose on 6/5/2021. Fatigue and chills started a few hours after second dose and then developed shortness of breath, nausea, emesis and 8/10 midsternal chest pain. Presented to an urgent care facility where CXR and EKG were obtained. EKG showed early repolarizations. Labs were obtained at a local ED and showed elevated troponins, initially 11k and then to 20k and peaked there. BNP was within normal limits. Subsequent EKG showed diffuse ST-segment elevations concerning for acute pericarditis. No prior infections or symptoms like this previously. He was given colchicine at outside facility prior to transfer. At hospital he was continued on ibuprofen and monitored with telemetry and had ECHO and cardiac MRI. Latter was consistent with myopericarditis. ECHO showed normal function. He received PPI while on NSAIDs. His symptoms resolved and he was discharged to home on 6/10/2021 with activity restrictions and plan to follow-up with peds cardiology. Of note, there was an error submitting the initial VAERS report for this patient during the admission, therefore, this delayed report is being submitted.
Macular papular rash and stomatitis on 10/29/2009. No fever. No hives. May have been caused by a viral illness but I am reporting it due to time frame.
Left deltoid - tenderness, swelling, redness, warmth, & tenderness to left axilla and left neck. Symptoms developed within 8 hours post vaccine administration time.
Bell's Palsy. Pt currently undergoing treatment with prednisone and valacylovir
This patient had a fever, fatigue, clouded thinking, swelling, pain and redness of left arm and left breast. She required time off from work; symptoms improved after 48 hours.
Client received vaccine and became dizzy and was "seeing stars". Sat for about 20 seconds right after being vaccinated and then passed out for 10 seconds. BP was unreadable, pulse 72, O2 saturation 98%. Was transported to hospital
Burning/dysesthesia at vaccine site - same arm arthralgia and myalgias for two weeks
little sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (little sore arm) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthmatic and Immunocompromised. Concomitant products included BUDESONIDE, FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]), FORMOTEROL FUMARATE, HYDROCHLOROTHIAZIDE, MELOXICAM, PANTOPRAZOLE, CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), LOSARTAN POTASSIUM, AMLODIPINE BESILATE (AMLODIPINE BESYLATE), PROBIOTICS NOS and VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (little sore arm). At the time of the report, PAIN IN EXTREMITY (little sore arm) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication was provided.  patient complaint about Moderna Vaccine lack of effectiveness literally said she questioning the effectiveness of it. In the study patient was tested for S and N proteins (probably talking about antibodies against those proteins). Patient was tested on 27 Jul 2021, then on 27 Oct 2021 and finally on 17 Jan 2022. S protein levels were 1993, 1019 and 197 for the 1st, 2nd and 3rd test, respectively. In all N protein  level was 0. Patient expected to increase or at least maintain the number after booster, but it dropped abruptly. After the 3 doses had a little sore arm for 24 hours. Spoke with HCP to receive advice but HCP said that the numbers mean nothing and refused doing a blood test. Patient asked if it was possible to find out any issues the vaccine might have undergone using the lot number.   This case was linked to MOD-2022-455735, MOD-2022-455714 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Jan-2022: Non significant follow up.
Patient immediately on administration became flushed, reported metallic taste in her mouth, thickening of her throat, and light headedness. VS, O2 6l/min via NC and EPI 0.3mg/0.3ml IM injection given and patient transferred to ED.
pt recv vax OCT95 & devel redness @ the inj site;no treatment necessary;pt recovered;
Dizziness; Tired; Weak; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weak), DIZZINESS (Dizziness) and FATIGUE (Tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced ASTHENIA (Weak) and FATIGUE (Tired). On 04-Mar-2021, the patient experienced DIZZINESS (Dizziness). On 27-Feb-2021, ASTHENIA (Weak) and FATIGUE (Tired) had resolved. At the time of the report, DIZZINESS (Dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications details were not reported by the reporter. Treatment information was not provided.
Patient was given his second dose of moderna covid-19 at 11:44am, around 11:52 am he began feeling dizzy and having trouble communicating his symptoms. I asked what he was experiencing and he kept pointing at his head and eyes and was unable to make complete sentences. His friend requested EMS to come check him out and as I was on the phone with dispatch he began feeling better. He stated he had not eaten or has anything to drink today and EMS checked his vitals and advised him to eat and drink water.
Pt recvd Hep B vax on 3JUL91; pt subsequently exp nerve problems; No further details were provided;
Information has been received from a physician concerning a female patient who on approximately 19-JUL-2010 was vaccinated with the second 0.5 ml dose of GARDASIL. The physician reported that about 24 hours after getting her second dose of the vaccine, on approximately 20-JUL-2010, the patient was given her 2nd injection she was congested and then developed a red and bumpy rash beneath armpits. It move to underneath her breasts, and then spread to all over her body. There was no adverse event after the first shot. At the time of the report the patient was recovering. No lab diagnostics studies were performed. The patient sought unspecified medical attention. Additional information has been requested.
Swelling of arm at area of injection,as well as,erythema, pruritis;and one round blotchy spot over deltoid
Chills, treated with acetaminophen and naproxen, starting same night as administration. Fatigue next day. (slept approximately 5 hours during the day)
23 year old young lady, 20 weeks pregnant, who presented with symptoms 2 weeks after her flu vaccination. Symptoms include numbness/tingling on right from armpit down the right side of her body, ataxia, She gradually after that developed what she describes as block of blue discoloration in her central vision in left eye, decreased vision (20/200) in L eye first, which then also occurred in her R eye this occurred approximately within the past 3 weeks. MRI is showing patterns and distribution most concerning of MS with active demyelination. Based on Neurology consult, they feel it could be related to the flu vaccination she had on January 5.
Patient was administered a Pfizer Covid-19 vaccine that was exposed to a temperature excursion. (Vaccine was between 8-14.5 degrees C for 7hrs and 48 minutes). Pfizer was contacted and advised the clinic to consider the dose as invalid and to revaccinate. Patient was revaccinated on 03/19/21 and has since received dose  on 04/09/21
This spontaneous report as received from a physician refers to a female patient of unknown age. No concurrent conditions or medical history were provided. On 26-JUN-2014 (reported as yesterday), The patient was vaccinated with a repeat dose of PNEUMOVAX23 25microgram/0.5ml injection, standard package vial of 2.5 ml, subcutaneously in her rear left deltoid region (dose, indication, lot#, expiry date unspecified). No concomitant medications were reported. Since receiving this injection (26-JUN-2014), the patient experienced itching red oval at injection site. This progressed to involve entire back of left arm and fluid was spending to elbow point. Area was red and tender. The patient sought medical attention. No care had been given at time of call. Physician commented that he had seen this before with one or two other patients after receiving PNEUMOVAX23. The outcome of events was unknown. The relatedness between event and PNEUMOVAX23 was not reported. This is one of several reports from the same source. Additional information is not expected. Permission for follow up was not obtained as the physician abruptly disconnected.
Client knowingly received dose #1 of the Moderna Covid-19 vaccine at the age of 17; on this date the client was not eligible to receive the Moderna vaccine, as not authorized for individuals under the age of 18 years of age. Client denies any adverse reactions post this vaccination, as did the accompanied parent.
Experiencing a fever of 100 degrees, dizziness, fatigue, and headache. Events have been ongoing for two days. I am approximately 8 weeks pregnant. Treating symptoms with Tylenol and ginger tea.
About an hour after her vaccination, she began to have welts rise in random spots around her body, this included arms, back and legs. Some were red and some that emerged began to turn white. The welt on the thigh was as big as mother's hand and they look closely like mosquito bites. Mother did try to get in touch with pediatrician however they were not able to get in touch with her as of yet. Mother did take participant to Pediatric emergency room where they treated her with benadryl for her symptoms. They were starting to go down prior to arriving to the ER, and with the Benadryl and the welts were almost completely gone by the time they left the ER around 05:45 PM same day.  Slight showing of welts on patient's arm was visible in morning today, however no Benadryl is needed as no discomfort is shown and patient seems to be doing fine and acting normal.
One day post vax the pt complained of right arm redness and warmth. On 5/4 the pt was seen by a medical care associate. The right upper extremities / shoulder was erythematous and indurated with warmth and tenderness to the touch. The pt had blister formation and was referred to hospital.
The pt experienced red blotches over the extremities and body. The baby was lethargic and afebrile.
Information has been received from a registered nurse (R.N.) concerning a 23 month old female patient who on 30-JUN-2010 was vaccinated with her first dose of MMR II (lot # unknown). The nurse stated that on 13-JUL-2010, "thirteen days post vaccination" child started shaking and had a seizure. Child was taken to the local emergency room (E.R.), but was not hospitalized. Diagnosis was febrile seizure possible due to the MMR II. On an unspecified date, the patient recovered from febrile seizure. Upon internal review, febrile seizure was considered to be other important medical event. No further information is available.
received the first dose of the vaccine on 21Dec2020 and tested positive for Covid-19; received the first dose of the vaccine on 21Dec2020 and tested positive for Covid-19; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date was not provided) via an unspecified route of administration on 21Dec2020 at single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received the first dose of the vaccine on 21Dec2020 and tested positive for covid-19 on 07Jan2021. The patient was isolated for 10 days. Outcome of event was unknown.  Information on the lot/batch number has been requested.
PT received Janessen Vaccine on 3/28/2021 and tested positive for COVID-19 via nasal swab on 5/28/2021.
cluster headaches on left side of head since 1991, joints and muscle pain, balance problems. Dry mouth, ear and sinus infection, lower back pain etc.
Fussiness; out of nowhere crying; Diarrhea; Temperature 99.9F; 3 month old received Flulaval; This case was reported by a physician via call center representative and described the occurrence of irritability in a 3-month-old female patient who received Flu Seasonal QIV (FluLaval Quadrivalent 2022-2023 season) (batch number 93CP5, expiry date 30th June 2023) for prophylaxis.   Co-suspect products included flu seasonal qiv pre-filled syringe device (Flulaval Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 10th February 2023, the patient received FluLaval Quadrivalent 2022-2023 season (intramuscular) and Flulaval Tetra Pre-Filled Syringe Device. On 10th February 2023, unknown after receiving FluLaval Quadrivalent 2022-2023 season and Flulaval Tetra Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On 21st February 2023, the patient experienced irritability, crying, diarrhea and fever. On an unknown date, the outcome of the irritability, crying, diarrhea, fever and inappropriate age at vaccine administration were unknown.   It was unknown if the reporter considered the irritability, crying, diarrhea and fever to be related to FluLaval Quadrivalent 2022-2023 season and Flulaval Tetra Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: Physician reports 3-month-old female patient was administered a dose of FluLaval QIV vaccine on 10th February 2023.  The physician states patient developed symptoms a few days ago on Tuesday, 21st February 2023 including fussiness, out of nowhere crying, diarrhea, temperature 99.9F. The physician unsure at this point if symptoms had resolved or not. Physician was unsure if the symptoms are related to the vaccine or not. The reporter consented to follow up.  The Vaccine Administration Facility was the same as Primary Reporter.
hallucinating; full day spent in bed feeling bad; chills; Body Aches; A little bit of a fever; didn't eat for 2 full days; This spontaneous case was reported by a consumer and describes the occurrence of HALLUCINATION (hallucinating) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 virus test positive (Patient with a prior, confirmed COVID 19 Infection requiring a ventilator in October and November.) in October 2020.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced FASTING (didn't eat for 2 full days), CHILLS (chills), MYALGIA (Body Aches) and PYREXIA (A little bit of a fever). On 23-Apr-2021, the patient experienced FEELING ABNORMAL (full day spent in bed feeling bad). On an unknown date, the patient experienced HALLUCINATION (hallucinating) (seriousness criterion medically significant). On 24-Apr-2021, HALLUCINATION (hallucinating), FASTING (didn't eat for 2 full days), FEELING ABNORMAL (full day spent in bed feeling bad), CHILLS (chills), MYALGIA (Body Aches) and PYREXIA (A little bit of a fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient took Blood pressure medicine(Name Not specified) and aspirin as a concomitant medication.  No treatment information was provided.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded
chills, fever, aches, nerve damage to hearing swollen tonsils, tinnutis
Significant increase in allergies with dermatitis and wheezing, persisting to present date, worsened further after second dose of vaccine 1/24/2022 Third dose of COVID vaccine was 11/18/2021 (Pfizer, lot number unavailable.)
So, I am 34 weeks pregnant; arm hurt; When I touch it, it hurts. If I lay it hurts.; I feel like my body, like muscle pain; Flu; This is a spontaneous report from a contactable consumer or other non hcp (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 09Sep2021 as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. On 09Sep2021, patient took Pfizer vaccine, about a week ago. Patient was 34 weeks pregnant (further clarification unknown. Hence, tab not checked). On an unspecified date she reported, she did not had any side effect, it's just that her arm was hurting, and it two days and then it did stop. Her arm started hurting again and she felt like her body, like muscle pain, like she is getting a flu. When she touches it, it hurts. If she lay it hurts. Now she felt like she is coming down with the flu. The mother reported she became pregnant while taking bnt162b2. The mother was 34 Weeks pregnant at the onset of the event. The mother was due to deliver on 26Sep2021. Outcome of all the events was unknown.  No follow up attempts are needed. Information on batch/lot number cannot be obtained.